Skip to content

Safety and Surgical Performance Study of Aurosleek Surgical Blades

A Prospective, Open Label, Observational Study To Evaluate The Safety And Surgical Performance Of Surgical Blade (Aurosleek) In Cataract Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01763593
Acronym
Aurosleek
Enrollment
35
Registered
2013-01-09
Start date
2013-03-31
Completion date
2013-06-30
Last updated
2013-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Keywords

Patients having cataract

Brief summary

To evaluate the safety and surgical effectiveness of surgical blades (Aurosleek) made by Aurolab.

Detailed description

Cataract till today remains the most common yet treatable cause of blindness accounting for more than 50% of blindness and visual impairment in the developing world. One of the most important features of a blade for cataract surgery is its predictable and repeatable behavior. The surgeon repeatedly and reliably needs to create similar tunnels of the proper length. Aurolab is producing surgical blades (Aurosleek) intended for making incision in cataract surgeries.

Interventions

None listed

Sponsors

Aurolab
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Senile cataract * Willing to give written informed consent * Ability to follow study instructions and likely to complete required visits.

Exclusion criteria

* Intraoperative complication including Posterior Capsular Rent and Zonular dialysis * Traumatic cataract * Uveitis and Complicated cataract * One eyed patients

Design outcomes

Primary

MeasureTime frameDescription
Physioclinical Characters30 daysAssessment of physio-clinical characteristics of surgical blade such as handling of the blade, sharpness and smoothness of blade. Handling of the surgical blade will be assessed in grades of difficult to handle,easy to handle and very easy to handle intraoperatively. Sharpness and smoothness of the blade will be rated as poor or optimum while performing cataract surgery.

Secondary

MeasureTime frameDescription
Post operative complications30 daysThe frequency and occurrence of post operative complications such as rhexis tear, posterior capsular rupture, severe corneal edema, severe iritis and anterior vitrectomy. Post operative complications occurrence due to surgical blade will be observed and graded as none or mild or moderate or severe at surgery and post operative 30 days.

Countries

India

Contacts

Primary ContactKarthikumar S, M.Pharm
crd@aurolab.com04523096100

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026